-
1دورية أكاديمية
المؤلفون: Akira Kurose, Fumihiko Okumura, Hiroaki Sakamoto, Hisashi Tanaka, Kageaki Taima, Kei Chubachi, Mayumi Nihei, Nobuhisa Yajima, Sadatomo Tasaka, Tomonori Makiguchi, Yoshiko Ishioka, Yume Nakamura
المصدر: Internal Medicine. 2023, 62(4):589
-
2دورية أكاديمية
المؤلفون: Tomonori Makiguchi, Takashi Fukushima, Hisashi Tanaka, Kageaki Taima, Shinobu Takayasu, Sadatomo Tasaka
المصدر: Thoracic Cancer, Vol 13, Iss 8, Pp 1220-1223 (2022)
مصطلحات موضوعية: COVID‐19 vaccination, diabetic ketoacidosis, immune checkpoint inhibitor, immune‐related adverse event, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, Tomonori Makiguchi, Megumi Inaba, Takeshi Honda, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Nobukazu Fujimoto, Yasushi Fukuda, Masayuki Yasugi, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
المصدر: Therapeutic Advances in Medical Oncology, Vol 14 (2022)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1758-8359Test
-
4دورية أكاديمية
المؤلفون: Haruka Odagiri, Hisashi Tanaka, Kageaki Taima, Masamichi Itoga, Sadatomo Tasaka, Takashi Fukushima, Tomonori Makiguchi, Yoshiko Ishioka, 小田切 遥, 牧口 友紀, 田中 寿志, 田坂 定智, 當麻 景章, 石岡 佳子, 福島 高志, 糸賀 正道
المصدر: 気管支学 / The Journal of the Japan Society for Respiratory Endoscopy. 2022, 44(5):325
-
5دورية أكاديمية
المؤلفون: Tomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, Kageaki Taima, Akira Kurose, Sadatomo Tasaka
المصدر: Thoracic Cancer, Vol 12, Iss 20, Pp 2811-2814 (2021)
مصطلحات موضوعية: amegakaryocytic thrombocytopenic purpura, concurrent chemoradiotherapy, immune checkpoint inhibitor, immune‐mediated thrombocytopenia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Shigeru Tanzawa, Tomonori Makiguchi, Sadatomo Tasaka, Megumi Inaba, Ryosuke Ochiai, Junya Nakamura, Koji Inoue, Takayuki Kishikawa, Masanao Nakashima, Keiichi Fujiwara, Tadashi Kohyama, Hiroo Ishida, Shoichi Kuyama, Naoki Miyazawa, Tomomi Nakamura, Hiroshi Miyawaki, Naohiro Oda, Nobuhisa Ishikawa, Ryotaro Morinaga, Kei Kusaka, Yosuke Miyamoto, Toshihide Yokoyama, Chiaki Matsumoto, Takeshi Tsuda, Sunao Ushijima, Kazuhiko Shibata, Takuo Shibayama, Akihiro Bessho, Kyoichi Kaira, Toshihiro Misumi, Kenshiro Shiraishi, Noriyuki Matsutani, Nobuhiko Seki
المصدر: Therapeutic Advances in Medical Oncology, Vol 14 (2022)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1758-8359Test
-
7دورية أكاديمية
المؤلفون: Tomonori Makiguchi, Akira Koarai, Chihiro Inoue, Yayoi Aoyama, Taizo Hirano, Takashi Ohe, Tomohiro Ichikawa, Yutaka Shishikura, Hanae Komuro, Yoko Tsukita, Naoki Tode, Tadahisa Numakura, Tsutomu Saito, Teruyuki Sato, Yoshiya Mitsuhashi, Tsutomu Tamada, Hisatoshi Sugiura, Masakazu Ichinose
المصدر: BMC Rheumatology, Vol 4, Iss 1, Pp 1-6 (2020)
مصطلحات موضوعية: Relapsing polychondritis, Tracheobronchial, Matrilin-1, Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2520-1026Test
-
8دورية أكاديمية
المؤلفون: Manabu Ono, Seiichi Kobayashi, Masakazu Hanagama, Masatsugu Ishida, Hikari Sato, Tomonori Makiguchi, Masaru Yanai
المصدر: PLoS ONE, Vol 15, Iss 11, p e0239764 (2020)
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1932-6203Test
-
9مؤتمر
المؤلفون: Hisashi Tanaka (158467), Shigeru Tanzawa (14280339), Toshihiro Misumi (651895), Tomonori Makiguchi (3585257), Megumi Inaba (6547850), Takeshi Honda (150171), Junya Nakamura (2178982), Koji Inoue (456339), Takayuki Kishikawa (14280342), Masanao Nakashima (14135086), Keiichi Fujiwara (234194), Tadashi Kohyama (673197), Hiroo Ishida (8282772), Shoichi Kuyama (9311677), Naoki Miyazawa (13903234), Tomomi Nakamura (136504), Hiroshi Miyawaki (9556162), Naohiro Oda (6173909), Nobuhisa Ishikawa (224940), Ryotaro Morinaga (14280345), Kei Kusaka (14280348), Nobukazu Fujimoto (81969), Yasushi Fukuda (7109687), Masayuki Yasugi (14280351), Takeshi Tsuda (9978357), Sunao Ushijima (14280354), Kazuhiko Shibata (8614500), Takuo Shibayama (9311674), Akihiro Bessho (14280357), Kyoichi Kaira (9439314), Kenshiro Shiraishi (818624), Noriyuki Matsutani (9588713), Nobuhiko Seki (6064028)
مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, cisplatin, chemoradiotherapy, durvalumab, non-small-cell lung cancer, S-1
-
10دورية أكاديمية
المؤلفون: Hisashi Tanaka (158467), Shigeru Tanzawa (14280339), Toshihiro Misumi (651895), Tomonori Makiguchi (3585257), Megumi Inaba (6547850), Takeshi Honda (150171), Junya Nakamura (2178982), Koji Inoue (456339), Takayuki Kishikawa (14280342), Masanao Nakashima (14135086), Keiichi Fujiwara (234194), Tadashi Kohyama (673197), Hiroo Ishida (8282772), Shoichi Kuyama (9311677), Naoki Miyazawa (13903234), Tomomi Nakamura (136504), Hiroshi Miyawaki (9556162), Naohiro Oda (6173909), Nobuhisa Ishikawa (224940), Ryotaro Morinaga (14280345), Kei Kusaka (14280348), Nobukazu Fujimoto (81969), Yasushi Fukuda (7109687), Masayuki Yasugi (14280351), Takeshi Tsuda (9978357), Sunao Ushijima (14280354), Kazuhiko Shibata (8614500), Takuo Shibayama (9311674), Akihiro Bessho (14280357), Kyoichi Kaira (9439314), Kenshiro Shiraishi (818624), Noriyuki Matsutani (9588713), Nobuhiko Seki (6064028)
مصطلحات موضوعية: Respiratory Diseases, Oncology and Carcinogenesis not elsewhere classified, Pharmacology and Pharmaceutical Sciences not elsewhere classified, Aged Health Care, cisplatin, chemoradiotherapy, durvalumab, non-small-cell lung cancer, S-1